Acetadote is used in the emergency department and administered intravenously within 8-10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen to prevent or lessen hepatic injury. Acetadote is the only injectable product approved in the U.S. to treat acetaminophen overdose.
Read the Cumberland Pharmaceuticals report on Acetadote.
Read more on supply chain issues:
–Study: Few Health Advocacy Groups Disclose Funding From Drug Makers
–Medline Launches Orthopedic Soft Goods Line
–New Device Manufacturer Tax Could Increase Medical Device Outsourcing
